Your browser doesn't support javascript.
loading
CTLA4 protects against maladaptive cytotoxicity during the differentiation of effector and follicular CD4+ T cells.
Hao, Yuwei; Miraghazadeh, Bahar; Chand, Rochna; Davies, Ainsley R; Cardinez, Chelisa; Kwong, Kristy; Downes, Morgan B; Sweet, Rebecca A; Cañete, Pablo F; D'Orsogna, Lloyd J; Fulcher, David A; Choo, Sharon; Yip, Desmond; Peters, Geoffrey; Yip, Sonia; Witney, Matthew J; Nekrasov, Maxim; Feng, Zhi-Ping; Tscharke, David C; Vinuesa, Carola G; Cook, Matthew C.
Afiliação
  • Hao Y; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Miraghazadeh B; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.
  • Chand R; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Davies AR; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Cardinez C; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.
  • Kwong K; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Downes MB; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Sweet RA; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.
  • Cañete PF; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • D'Orsogna LJ; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Fulcher DA; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.
  • Choo S; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Yip D; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Peters G; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.
  • Yip S; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Witney MJ; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Nekrasov M; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.
  • Feng ZP; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Tscharke DC; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Vinuesa CG; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.
  • Cook MC; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Cell Mol Immunol ; 20(7): 777-793, 2023 07.
Article em En | MEDLINE | ID: mdl-37161048
ABSTRACT
As chronic antigenic stimulation from infection and autoimmunity is a feature of primary antibody deficiency (PAD), analysis of affected patients could yield insights into T-cell differentiation and explain how environmental exposures modify clinical phenotypes conferred by single-gene defects. CD57 marks dysfunctional T cells that have differentiated after antigenic stimulation. Indeed, while circulating CD57+ CD4+ T cells are normally rare, we found that they are increased in patients with PAD and markedly increased with CTLA4 haploinsufficiency or blockade. We performed single-cell RNA-seq analysis of matched CD57+ CD4+ T cells from blood and tonsil samples. Circulating CD57+ CD4+ T cells (CD4cyt) exhibited a cytotoxic transcriptome similar to that of CD8+ effector cells, could kill B cells, and inhibited B-cell responses. CTLA4 restrained the formation of CD4cyt. While CD57 also marked an abundant subset of follicular helper T cells, which is consistent with their antigen-driven differentiation, this subset had a pre-exhaustion transcriptomic signature marked by TCF7, TOX, and ID3 expression and constitutive expression of CTLA4 and did not become cytotoxic even after CTLA4 inhibition. Thus, CD57+ CD4+ T-cell cytotoxicity and exhaustion phenotypes are compartmentalised between blood and germinal centers. CTLA4 is a key modifier of CD4+ T-cell cytotoxicity, and the pathological CD4cyt phenotype is accentuated by infection.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Linfócitos T CD4-Positivos Limite: Humans Idioma: En Revista: Cell Mol Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Linfócitos T CD4-Positivos Limite: Humans Idioma: En Revista: Cell Mol Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália
...